We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Bristol-Myers Squibb is unloading a clinical materials manufacturing facility and labs in Washington to Seattle Genetics, which has agreed to keep on the workers employed there.